Step Away From Depression - Evaluation of a Pedometer Intervention With Inpatients With Major Depression (SAD)

August 27, 2021 updated by: Prof. Dr. Andreas Ströhle, Charite University, Berlin, Germany

Step Away From Depression - Evaluation of a Pedometer Intervention With Inpatients With Major Depression - A Randomized Controlled Trial

The purpose of this study is to determine if the use of pedometers can help depressive inpatients in psychiatric clinics to increase their level of physical activity. Therefore patients are given a pedometer and instructions how to raise their level of daily steps. Intervention group is compared with a control group that is receiving treatment-as-usual. The intervention is hypothesized to increase number of daily steps and have positive effects on mood, depression and anxiety.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

292

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Salzburg, Austria, 5020
        • Paracelsus University Salzburg - Clinic for Psychiatry and Psychotherapy
      • Berlin, Germany, 10117
        • Charité Universitätsmedizin Berlin - Departement of Psychiatry
    • Bayern
      • Munich, Bayern, Germany, 80366
        • Ludwig Maximilian University Munich - Clinic for Psychiatry and Psychotherapy
    • Brandenburg
      • Hennigsdorf, Brandenburg, Germany, 16761
        • Oberhavel Clinics GmbH - Clinic for Psychiatry, Psychosomatics and Psychotherapy
    • Hessen
      • Erbach, Hessen, Germany, 64711
        • Health Center Odenwaldkreis GmbH - Center for Mental Health
      • Frankfurt am Main, Hessen, Germany, 60528
        • University of Frankfurt/Main - Clinic for Psychiatry, Psychosomatic and Psychotherapy
    • Niedersachsen
      • Göttingen, Niedersachsen, Germany, 37075
        • University of Göttingen - Clinic for Psychiatry and Psychotherapy
    • Nordrhein-Westfalen
      • Aachen, Nordrhein-Westfalen, Germany, 52074
        • University RWTH Aachen, Clinic for Psychiatriy, Psychotherapy and Psychosomatic
    • Schleswig-Holstein
      • Flensburg, Schleswig-Holstein, Germany, 24939
        • Ev.Luth. Diakonissenanstalt Flensburg - Clinic for Psychiatry, Psychosomatic and Psychotherapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Major Depression, moderate to severe as main diagnosis
  • Inpatient status
  • Prospected inpatient treatment of at least 4 weeks
  • Able to understand german

Exclusion Criteria:

  • Physical disease or disability that makes it impossible to reach the goal 5000 steps per day
  • Borderline personality disorder
  • Bipolar Disorder
  • Schizophrenia
  • Anorexia Nervosa
  • Dementia
  • Psychotic Depression
  • Pregnancy
  • Acute suicidality
  • Substance dependancies with actual consumption (except nicotine)
  • Current pedometer-use
  • More than 10.000 steps per day

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Intervention group
Patients receive a pedometer and instructions how to raise their physical activity
Patients receive a pedometer with instructions how to raise their number of daily steps
NO_INTERVENTION: Control group
Patients receive treatment-as-usual

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in average number of steps per day
Time Frame: From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Number of steps per day is objectively measured using accelerometry (ActiGraph GT1M)
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Change in depressive symptoms - clinician rated
Time Frame: From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Depressive symptoms are rated by a blind study employee using MADRS
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in physical activity - subjective
Time Frame: From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Physical activity is subjectively measured with the International Physical Activity Questionnaire (IPAQ)
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Change in physical activity - objective
Time Frame: From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Physical activity is objectively measured using accelerometry (ActiGraph GT1M)
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Change in psychopathological symptoms
Time Frame: From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Psychopathological symptoms are measured by the Symptom Checklist 27 (SCL-27)
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Change in health-related quality of life
Time Frame: From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Health-related quality of life is measured using the Short-Form Health Questionnaire (SF-12)
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Change in depressive symptoms
Time Frame: From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Depressive symptoms are measured using the Beck Depression Inventory (BDI II)
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Change in anxiety symptoms
Time Frame: From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Anxiety symptoms are measured using the Beck Anxiety Inventory (BAI)
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Change in self-efficacy for physical activity
Time Frame: From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Self-efficacy for physical activity is measured using six likert scaled items by Scholz, U., Sniehotta, F. & Schwarzer, R. (2005)
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Change in intention for physical activity
Time Frame: From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Intention for physical activity is measured using two likert scaled items by Sniehotta, F. F., Schwarzer, R., Scholz, U., & Schüz, B. (2005)
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Change in self concordance of the motivation for physical activity
Time Frame: From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Self concordance of the Motivation for physical activity is measured using the "Sport- und bewegungsbezogene Selbstkonkordanz Skala", which consists of 12 likert scaled items
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Change in outcome expectancies for physical activity
Time Frame: From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Outcome expectancies for physical activity are measured using 6 likert scaled items by Lippke S., Ziegelmann, J. P. & Schwarzer, R. (2005)
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Change in planning and barrier planning for physical activity
Time Frame: From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Planning and barrier planning for physical activity is measured using 8 likert scaled items by Sniehotta, F. F. et al. (2005) / Renner, B. (2007)
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Duration of inpatient treatment (Number of days)
Time Frame: Duration of inpatient treatment is assessed at the end of inpatient treatment
Duration of inpatient treatment is assessed at the end of inpatient treatment
Change in general self-efficacy
Time Frame: From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
General self-efficacy is measured using the General-Self-Efficacy Scale (GSE)
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Andreas Ströhle, Prof.Dr., Charité Universitätsmedizin Berlin - Klinik für Psychiatrie und Psychotherapie

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2016

Primary Completion (ACTUAL)

January 1, 2020

Study Completion (ACTUAL)

January 1, 2020

Study Registration Dates

First Submitted

July 22, 2016

First Submitted That Met QC Criteria

July 27, 2016

First Posted (ESTIMATE)

August 1, 2016

Study Record Updates

Last Update Posted (ACTUAL)

September 1, 2021

Last Update Submitted That Met QC Criteria

August 27, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Pedometer

3
Subscribe